Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study

INTRODUCTION: Hyperkalemia (HK) may result in disruptions of guidelines-concordant renin-angiotensin-aldosterone system inhibitors (RAASi), a standard of care in persons with chronic kidney disease (CKD). Such disruptions—dose reduction or discontinuation—diminish the benefits of RAASi, placing pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Agiro, Abiy, AN, Amin, Cook, Erin E., Mu, Fan, Chen, Jingyi, Desai, Pooja, Oluwatosin, Yemmie, Pollack, Charles V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220114/
https://www.ncbi.nlm.nih.gov/pubmed/37140706
http://dx.doi.org/10.1007/s12325-023-02518-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220114/
https://www.ncbi.nlm.nih.gov/pubmed/37140706
http://dx.doi.org/10.1007/s12325-023-02518-w

Ejemplares similares